Evidence map›Paper›PMID 19395447›Full record

ArticleThe Journal of endocrinology2009

The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms.

Michael J F Newson, Emma M Roberts, George R Pope, Stephen J Lolait, Anne-Marie O'Carroll

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role of Adipokines in the Control of Pituitary Functions.Animals : an open access journal from MDPI · 2024
    Review
  4. Article
  5. The Apelinergic System in Pregnancy.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. A network map of apelin-mediated signaling.Journal of cell communication and signaling · 2022
    Article
  9. Article
  10. Review
  11. Plasma Apelin, Visfatin and Resistin Levels in Patients with First Episode Psychosis and Chronic Schizophrenia.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  12. Study on Neuroendocrine-Immune Function ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  13. Article
  14. Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael J F NewsonHenry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol, UK.
Emma M Roberts
George R Pope
Stephen J Lolait
Anne-Marie O'Carroll
University of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D00196X/1Wellcome Trust 074690Wellcome Trust 076321
6 · The paper itself

Abstract

The apelinergic system has a widespread expression in the central nervous system (CNS) including the paraventricular nucleus, supraoptic nucleus and median eminence, and isolated cells of the anterior lobe of the pituitary. This pattern of expression in hypothalamic nuclei known to contain corticotrophin-releasing factor (CRF) and vasopressin (AVP) and to co-ordinate endocrine responses to stress has generated interest in a role for apelin in the modulation of stress, perhaps via the regulation of hormone release from the pituitary. In this study, to determine whether apelin has a central role in the regulation of CRF and AVP neurones, we investigated the effect of i.c.v. administration of pGlu-apelin-13 on neuroendocrine function in male mice pre-treated with the CRF receptor antagonist, alpha-helical CRF(9-41), and in mice-lacking functional AVP V1b receptors (V1bR KO). Administration of pGlu-apelin-13 (1 mg/kg i.c.v.) resulted in significant increases in plasma ACTH and corticosterone (CORT), which were significantly reduced by pre-treatment with alpha-helical CRF(9-41), indicating the involvement of a CRF-dependent mechanism. Additionally, pGlu-apelin-13-mediated increases in both plasma ACTH and CORT were significantly attenuated in V1bR KO animals when compared with wild-type controls, indicating a role for the vasopressinergic system in the regulation of the effects of apelin on neuroendocrine function. Together, these data confirm that the in vivo effects of apelin on hypothalamic-pituitary-adrenal neuroendocrine function appear to be mediated through both CRF- and AVP-dependent mechanisms.

Indexed as

AnimalsCorticotropin-Releasing HormoneHormone AntagonistsHydrocortisoneHypothalamo-Hypophyseal SystemIntercellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutNeurosecretory SystemsPeptide FragmentsPituitary-Adrenal SystemReceptors, Corticotropin-Releasing HormoneReceptors, VasopressinSignal Transductionapelin-13 peptideCorticotropin-Releasing Hormonecorticotropin releasing hormone (9-41)Hormone AntagonistsHydrocortisoneIntercellular Signaling Peptides and ProteinsPeptide FragmentsReceptors, Corticotropin-Releasing HormoneReceptors, VasopressinVasopressins

Identifiers

PMID19395447
PMCPMC2695660
OpenAlexW2163524075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.